Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
News in Brief
Doctors in the News
FDA News
Industry News
Drugs in the Pipeline
Daily Nephrology News
Daily Urology News
Newsletters
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Hypogonadism
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Nephrology
Acute Kidney Injury
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hyperphosphatemia
Hypertension
Hyperuricemia
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Departments
On The Forefront
Your Practice
Your Money
Legal Issues in Medicine
Malpractice News
World Literature Review
Video Interviews
Conferences
Meetings Calendar
EAU Annual Congress
Genitourinary Cancers Symposium
Kidney Week 2011
International Continence Society
AUA 2011
NKF 2011
ERA-EDTA 2011 Congress
American Transplant Congress
World Congress of Nephrology
Annual Dialysis Conference
AUA Annual Meeting
ASH Annual Meeting
Canadian Urological Association Annual Meeting
NKF 2010 Spring Meetings
NKF 2009
Renal Week 2010
Renal Week 2009
Renal Week 2008
Clinical Trials
Acute Kidney Injury
Bladder Cancer
Diabetes Mellitus
Hemodialysis
Hyperphosphatemia
Kidney/Ureteral Stones
Lupus Nephritis
Nephrogenic Systemic Fibrosis
Overactive Bladder
Pelvic Prolapse
Prostate Cancer
Renal Cell Carcinoma
Renal Obstruction
Renal Transplant
Voiding Dysfunction
Directories
Nephrology Buyer's Guide
Urology Buyer's Guide
Dialysis Directory
CME
CME Articles
mycme.com
Resources
View Full Issue
Links
Crossword Puzzles
Clinical Quiz
Cartoons
Expert Q&A
Renal Nutrition Update
Commentary
Features
Medical Minute
Polls
Drug Info
Jobs
RSS
|
Login
|
Register
RUN
>
News & Features
> FDA News
FDA News
FDA Committee Favors Peginesatide
Stephan Cho
December 15, 2011
The FDA's Oncologic Drugs Advisory Committee, in a 15 to 1 vote, has agreed that peginesatide demonstrates a favorable benefit/risk profile for use in treatment of dialysis patients with anemia resulting from chronic kidney disease (CKD).
Long-Acting Drug for Post-Op Pain Approved
Stephan Cho
November 01, 2011
The FDA has approved Exparel (bupivacaine), a single-dose injection that provides post-surgical pain relief for up to 72 hours.
Drug Cleared for Treating ADT-Related Bone Loss in Prostate Cancer Patients
Jody A. Charnow
September 19, 2011
The FDA has approved denosumab (Prolia) as a treatment to increase bone mass in prostate cancer patients at high risk for fracture undergoing androgen deprivation therapy (ADT) and women with breast cancer at high risk for fracture who are receiving aromatase inhibitor therapy.
FDA Issues Surgical Mesh Safety Alert
Jody A. Charnow
August 01, 2011
The FDA recently issued a safety alert regarding placement of surgical mesh as a treatment for pelvic organ prolapse (POP).
New Indication Okayed for Chronic Hepatitis B Drug
Delicia Honen Yard
November 16, 2010
Bristol-Myers Squibb of Princeton, N.J., has received FDA approval to market Baraclude (entecavir) as a treatment for chronic hepatitis B (CHB) patients with evidence of decompensated liver disease.
New Oral Anticoagulant Cleared for Reducing Stroke Risk
Delicia Honen Yard
November 16, 2010
Pradaxa (dabigatran etexilate) capsules have received FDA approval for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).
FDA Takes On Unapproved Single-Ingredient Colchicine
Delicia Honen Yard
November 16, 2010
The FDA has ordered a halt to the marketing of unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of familial Mediterranean fever.
Brand Name for Epoprostenol for Injection Okayed
Delicia Honen Yard
October 29, 2010
The FDA has approved the brand name for commercially available Veletri (epoprostenol for injection) for pulmonary arterial hypertension (PAH).
Withdrawal of Approval for Midodrine Proposed
Delicia Honen Yard
October 29, 2010
The FDA has proposed withdrawing approval of midodrine, a drug used to treat orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the medication have not been done, the agency announced.
Drug for Chronic Refractory Gout Approved
Delicia Honen Yard
October 29, 2010
Savient Pharmaceuticals, Inc., of East Brunswick, N.J., has received FDA clearance to market Krystexxa (pegloticase) as a treatment for chronic gout in adult patients refractory to conventional treatment.
Ultra-Fine Pen Needle for Diabetics Debuts
Jody A. Charnow
July 27, 2010
Becton, Dickinson and Company (BD), based in Franklin Lakes, N.J., has launched the BD Ultrafine Nano, which the company says is the world's smallest pen needle.
Over the Counter Pain Relief Patches Introduced
Jody A. Charnow
July 27, 2010
Hisamitsu Pharmaceutical, which has U.S. headquarters in Torrance, Calif., has introduced two over-the-counter pain relief patches to the American market, the Salonpas Pain Relief Patch and Salonpas Arthritis Pain patch.
Marketing Clearance Granted to New Glucose Test Strips
Jody A. Charnow
July 27, 2010
Abbott has received FDA clearance to market FreeStyle Lite glucose test strips. The test strips minimize interference during blood glucose testing and are designed to offer a better experience, Abbott says.
Imaging Agent for Bladder Cancer Okayed
Jody A. Charnow
July 27, 2010
The FDA has approved Cysview (hexaminolevulinate HCl), an optical imaging agent indicated for use in the cystoscopic detection of non-muscle-invasive papillary bladder cancer in patients suspected or known to have lesions on the basis of prior cystoscopy.
FDA Mulls Application for Prostate Imaging Device
Jody A. Charnow
July 27, 2010
ProUroCare Medical, Inc., of Minneapolis, Minn., has filed a de novo application with the FDA seeking marketing clearance for its prostate mechanical imaging (PMI) device (ProUroScan).
Intranasal Ketorolac Cleared for Pain Management
Jody A. Charnow
June 14, 2010
A novel prescription intranasal formulation of ketorolac tromehtamine (Sprix Nasal Spray), a non-steroidal anti-inflammatory drug, has been approved for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level.
GnRH Agonist Safety Is Under Review
Jody A. Charnow
June 14, 2010
The FDA is conducting a safety review of gonadotropin-releasing hormone (GnRH) agonists, a class of drugs used primarily as a treatment for prostate cancer.
Home Hemodialysis Safety Device Approved
Jody A. Charnow
June 14, 2010
The Redsense safety device, which is designed to detect venous needle displacement during hemodialysis (HD), has received FDA approval for home/self use during home HD, according to the device's manufacturer, Redsense Medical.
Company Introduces Its Novel Male Sling for SUI
Jody A. Charnow
June 14, 2010
San Francisco-based Coloplast has announced the debut of a new sling for treating male stress urinary incontinence (SUI).
Lower Dosage Strength Sirolimus Tablets Available
Jody A. Charnow
June 14, 2010
A lower dosage strength sirolimus (Rapamune) tablet is now commercially available, according to the drug's maker, Pfizer Inc., of New York.
more »
CME SPOTLIGHT
Androgen Deprivation Therapy in Prostate Cancer: Addressing Clinical Challenges
1.00 / AMA PRA Category 1 Credit(s)™
Click here for more courses
Legal Issues
Physician Sued For Failing to Follow Up
A primary care doctor referred a patient with an elevated PSA to a urologist. After a negative prostate biopsy, the doctor did not regularly conduct follow-up PSA testing, and the patient eventually died from prostate cancer.
Newsletters
Sign up
to start receiving free e-newsletters from
Renal & Urology News
, including:
Latest CME
Ongoing Clinical Trials
Conference Highlights
Expert Q&A
Weekly Round-Up
Most Popular
Most Emailed
Most Recent
Active Surveillance An Option for Bladder Cancer
PCA3 Test Okayed to Help Decide Need for Repeat Prostate Biopsy
Dietary Calcium May Decrease Prostate Cancer Risk
Biomarkers Identify Acute Kidney Injury in Emergency Patients
Minnesota Medical Board Comes Under Scrutiny
Patient Compensation System Considered in Florida
Arizona Senate Panel Votes to Curb 'Wrongful Birth' Suits
More Tailored Treatments for Kidney Cancer Possible
Study: Form of Bladder Cancer Increased by 56%
A New Radiotherapy Option for Prostate Cancer
Proton Therapy No Better than IMRT for Prostate Cancer
Online Tools Increase Efficiency, Speed of Kidney Donor Screening
Remote Care: How to Use Telemedicine
The Management of Patients After Renal Transplantation
Substances in Coffee May Prevent, Treat Diabetes
Prostate Cancer Linked to Heavy Alcohol Intake
First PSA Results Predict Long-Term Prostate Cancer Risk
Empiric Antibiotics for Elevated PSA of No Clinical Benefit
Let Patients Sleep During Rounds
Dutasteride Delays Progression of Low-Risk Prostate Cancer
Study: Form of Bladder Cancer Increased by 56%
A New Radiotherapy Option for Prostate Cancer
Biomarkers Identify Acute Kidney Injury in Emergency Patients
Open-Angle Glaucoma, Erectile Dysfunction Linked
Dietary Calcium May Decrease Prostate Cancer Risk
Patient Compensation System Considered in Florida
Minnesota Medical Board Comes Under Scrutiny
Arizona Senate Panel Votes to Curb 'Wrongful Birth' Suits
Active Surveillance An Option for Bladder Cancer
More Tailored Treatments for Kidney Cancer Possible
Popular Topics
Acute Kidney Injury
Anemia
Bladder Cancer
BPH
Cardiovascular Disease
Chronic Kidney Disease
CKD
Diabetes
Epidemiology
Erectile Dysfunction
Hemodialysis
Hyperphosphatemia
Hypertension
Infection
Kidney Cancer
Kidney Stones
Nutrition
Overactive Bladder
Peritoneal Dialysis
Prostate Cancer
PSA
Reproductive Medicine
Transplantation
Urinary Incontinence
UTI